MIREN
ZULAICA IJURCO
Ikertzailea 2022-(e)ra arte
![Foto de MIREN](/img/nophoto.png)
![Foto de Max Planck Institute of Psychiatry](/img/noimage_org.png)
Max Planck Institute of Psychiatry
Múnich, AlemaniaMax Planck Institute of Psychiatry-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2019
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250